Pancreatic Cancer Research

ResearcherKaohsiung Medical UniversityNo recent work listed

Jeffrey Shu-Ming Chang

Matched on ORCID iD 0000-0002-3236-6205; OpenAlex author ID A5062702260. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 6

  1. No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol. Last author DOI 10.1038/s41598-021-94111-w↗
  2. Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan. Last author DOI 10.1186/s12929-020-00664-9↗
  3. Environmental Risk Factors of Pancreatic Cancer. First author DOI 10.3390/jcm8091427↗
  4. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan. Co-author DOI 10.1002/cam4.1795↗
  5. The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis. Co-author DOI 10.4143/crt.2017.105↗
  6. Investigating the Association Between Periodontal Disease and Risk of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000419↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hui‐Jen Tsai · 4 shared papers, 2018–2021 · strength 0.50
  2. Li‐Tzong Chen · 5 shared papers, 2016–2021 · strength 0.49
  3. Yan‐Shen Shan · 3 shared papers, 2016–2021 · strength 0.29
  4. Nai‐Jung Chiang · 2 shared papers, 2020–2021 · strength 0.20
  5. Ying‐Jui Chao · 2 shared papers, 2020–2021 · strength 0.20
  6. Yen‐Feng Chiu · 1 shared paper, 2018 · strength 0.11
  7. Hui-Ju Ch’ang · 1 shared paper, 2018 · strength 0.11
  8. Yan-Shen Shan · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.